CGM for Insulin-Treated T2DM During Post-Discharge Transition

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.

Also called NCT07414277

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07414277
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07414277. Randomized; no masking; primary purpose treatment. Start 2026-05-11 (actual); primary completion 2027-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CGM for Insulin-Treated T2DM During Post-Discharge Transition
Acronym
TRANSIT-CGM
Condition
Type 2 Diabetes Mellitus (T2DM)
Intervention (Device)
RT-CGM
Intervention (Device)
SMBG
Lead sponsor
Shanghai 6th People's Hospital (class: other)
Collaborator
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (class: other)
Collaborator
Shanghai Fengxian District Central Hospital (class: other)
Collaborator
Shanghai 7th People's Hospital (class: other)

Record details

Record id
cardio:ct-nct07414277
Content hash
62ba114520d62cbde284171b1f57ccfba44c387c442810ffd017399eb3fd592b